Japan Net Tangible Assets from 2010 to 2026
| JMD Stock | EUR 3.62 0.02 0.56% |
Net Tangible Assets | First Reported 2017-03-31 | Previous Quarter 22.9 B | Current Value 23.8 B | Quarterly Volatility 3.8 B |
Check Japan Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Japan Medical's main balance sheet or income statement drivers, such as Interest Expense of 91 M, Selling General Administrative of 3.1 B or Total Revenue of 18.6 B, as well as many indicators such as . Japan financial statements analysis is a perfect complement when working with Japan Medical Valuation or Volatility modules.
Japan | Net Tangible Assets |
The Net Tangible Assets trend for Japan Medical Dynamic offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Japan Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Japan Medical's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Japan Medical Dynamic over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Japan Medical's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Japan Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Japan Net Tangible Assets Regression Statistics
| Arithmetic Mean | 16,103,004,706 | |
| Geometric Mean | 15,308,708,774 | |
| Coefficient Of Variation | 33.31 | |
| Mean Deviation | 4,594,593,218 | |
| Median | 15,006,000,000 | |
| Standard Deviation | 5,363,782,423 | |
| Sample Variance | 28770161.9T | |
| Range | 15.6B | |
| R-Value | 0.88 | |
| Mean Square Error | 6995077.9T | |
| R-Squared | 0.77 | |
| Slope | 933,311,127 | |
| Total Sum of Squares | 460322590.1T |
Japan Net Tangible Assets History
About Japan Medical Financial Statements
Japan Medical stakeholders use historical fundamental indicators, such as Japan Medical's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Japan Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Japan Medical's assets and liabilities are reflected in the revenues and expenses on Japan Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Japan Medical Dynamic. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 26.3 B | 16.7 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Japan Stock
Japan Medical financial ratios help investors to determine whether Japan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Japan with respect to the benefits of owning Japan Medical security.